The relationship between systolic function and serum NGAL levels in patients with chronic heart failure of ischemic origin

Neutrophil gelatinase-associated lipocalin (NGAL) is considered one of the most informative biomarkers of chronic kidney disease (CKD). NGAL can also serve as a biomarker of cardiovascular disease and heart failure (HF). However, the relationship between systolic function and serum NGAL concentratio...

Full description

Saved in:
Bibliographic Details
Main Authors: V. A. Lysenko, V. V. Syvolap, M. S. Potapenko
Format: Article
Language:English
Published: Zaporizhzhia State Medical and Pharmaceutical University 2021-04-01
Series:Zaporožskij Medicinskij Žurnal
Subjects:
Online Access:http://zmj.zsmu.edu.ua/article/view/223741/228110
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850235966774575104
author V. A. Lysenko
V. V. Syvolap
M. S. Potapenko
author_facet V. A. Lysenko
V. V. Syvolap
M. S. Potapenko
author_sort V. A. Lysenko
collection DOAJ
description Neutrophil gelatinase-associated lipocalin (NGAL) is considered one of the most informative biomarkers of chronic kidney disease (CKD). NGAL can also serve as a biomarker of cardiovascular disease and heart failure (HF). However, the relationship between systolic function and serum NGAL concentrations in patients with chronic HF (CHF) of ischemic origin remains insufficiently studied. The aim. To study the influence of tubulo-interstitial injury marker NGAL on systolic function in patients with CHF of ischemic origin. Materials and methods. The study included 51 patients with CHF, stage II AB, NYHA II-IV FC. Doppler echocardiographic examination was performed on the device Esaote MyLab Eight (Italy) according to standard methods. NGAL levels were analyzed using an ELISA kit (E-EL-H0096, Elabscience, USA). Depending to the concentration of serum NGAL, the patients were divided into 2 subgroups. In the first group (n = 37), the NGAL level was higher than 168 ng/ml, in the second (n = 14) – less than 168 ng/ml. Results. The mean serum NGAL concentration in the first subgroup was 192 (183; 200) ng/ml, in the second subgroup – 154 (134; 160) ng/ml. The patients with CHF of ischemic origin with tubulo-interstitial injury (according to the serum concentration of NGAL) did not differ significantly from the patients with CHF of ischemic origin without tubulo-interstitial injury in age (P = 0.950), height (P = 0.983), weight (P = 0.681), body surface area (P = 0.975). Most of left ventricular systolic function indicators showed a downward tendency (S 6.90 ± 2.85 cm/s vs. 7.67 ± 2.83 cm/s (P = 0.536); S lat 7.33 ± 2.08 cm/s vs. 11.00 ± 4.00 cm/s (P = 0.467); TEI LV 0.56 ± 0.26 c.u. vs. 0.49 ± 0.14 c.u. (P = 0.747)) in the patients with CHF of ischemic origin with elevated serum levels of NGAL compared to similar indicators in the patients with CHF of ischemic origin without tubulo-interstitial injury. The index of LVEF was significantly lower in the patients with CHF with elevated serum NGAL compared to that in the patients with CHF with normal serum NGAL (50.43 ± 17.85 % vs. 63.29 ± 13.24 % (P = 0.021)). Conclusions. Serum NGAL was not only the sensitive marker of tubulo-interstitial injury in patients with CHF of ischemic origin, but also appeared to be a predictor of changes in systolic heart function.
format Article
id doaj-art-c9030977cfce46ef943ca5edf36b82f5
institution OA Journals
issn 2306-4145
2310-1210
language English
publishDate 2021-04-01
publisher Zaporizhzhia State Medical and Pharmaceutical University
record_format Article
series Zaporožskij Medicinskij Žurnal
spelling doaj-art-c9030977cfce46ef943ca5edf36b82f52025-08-20T02:02:05ZengZaporizhzhia State Medical and Pharmaceutical UniversityZaporožskij Medicinskij Žurnal2306-41452310-12102021-04-0123218418810.14739/2310-1210.2021.2.223741The relationship between systolic function and serum NGAL levels in patients with chronic heart failure of ischemic originV. A. Lysenko0https://orcid.org/0000-0001-7502-0127V. V. Syvolap1https://orcid.org/0000-0001-9865-4325M. S. Potapenko 2Zaporizhzhia State Medical University, UkraineZaporizhzhia State Medical University, UkraineZaporizhzhia State Medical University, UkraineNeutrophil gelatinase-associated lipocalin (NGAL) is considered one of the most informative biomarkers of chronic kidney disease (CKD). NGAL can also serve as a biomarker of cardiovascular disease and heart failure (HF). However, the relationship between systolic function and serum NGAL concentrations in patients with chronic HF (CHF) of ischemic origin remains insufficiently studied. The aim. To study the influence of tubulo-interstitial injury marker NGAL on systolic function in patients with CHF of ischemic origin. Materials and methods. The study included 51 patients with CHF, stage II AB, NYHA II-IV FC. Doppler echocardiographic examination was performed on the device Esaote MyLab Eight (Italy) according to standard methods. NGAL levels were analyzed using an ELISA kit (E-EL-H0096, Elabscience, USA). Depending to the concentration of serum NGAL, the patients were divided into 2 subgroups. In the first group (n = 37), the NGAL level was higher than 168 ng/ml, in the second (n = 14) – less than 168 ng/ml. Results. The mean serum NGAL concentration in the first subgroup was 192 (183; 200) ng/ml, in the second subgroup – 154 (134; 160) ng/ml. The patients with CHF of ischemic origin with tubulo-interstitial injury (according to the serum concentration of NGAL) did not differ significantly from the patients with CHF of ischemic origin without tubulo-interstitial injury in age (P = 0.950), height (P = 0.983), weight (P = 0.681), body surface area (P = 0.975). Most of left ventricular systolic function indicators showed a downward tendency (S 6.90 ± 2.85 cm/s vs. 7.67 ± 2.83 cm/s (P = 0.536); S lat 7.33 ± 2.08 cm/s vs. 11.00 ± 4.00 cm/s (P = 0.467); TEI LV 0.56 ± 0.26 c.u. vs. 0.49 ± 0.14 c.u. (P = 0.747)) in the patients with CHF of ischemic origin with elevated serum levels of NGAL compared to similar indicators in the patients with CHF of ischemic origin without tubulo-interstitial injury. The index of LVEF was significantly lower in the patients with CHF with elevated serum NGAL compared to that in the patients with CHF with normal serum NGAL (50.43 ± 17.85 % vs. 63.29 ± 13.24 % (P = 0.021)). Conclusions. Serum NGAL was not only the sensitive marker of tubulo-interstitial injury in patients with CHF of ischemic origin, but also appeared to be a predictor of changes in systolic heart function.http://zmj.zsmu.edu.ua/article/view/223741/228110serum ngalleft ventricular systolic functionchronic heart failure of ischemic originrenal dysfunctionbiomarker of tubulo-interstitial injury
spellingShingle V. A. Lysenko
V. V. Syvolap
M. S. Potapenko
The relationship between systolic function and serum NGAL levels in patients with chronic heart failure of ischemic origin
Zaporožskij Medicinskij Žurnal
serum ngal
left ventricular systolic function
chronic heart failure of ischemic origin
renal dysfunction
biomarker of tubulo-interstitial injury
title The relationship between systolic function and serum NGAL levels in patients with chronic heart failure of ischemic origin
title_full The relationship between systolic function and serum NGAL levels in patients with chronic heart failure of ischemic origin
title_fullStr The relationship between systolic function and serum NGAL levels in patients with chronic heart failure of ischemic origin
title_full_unstemmed The relationship between systolic function and serum NGAL levels in patients with chronic heart failure of ischemic origin
title_short The relationship between systolic function and serum NGAL levels in patients with chronic heart failure of ischemic origin
title_sort relationship between systolic function and serum ngal levels in patients with chronic heart failure of ischemic origin
topic serum ngal
left ventricular systolic function
chronic heart failure of ischemic origin
renal dysfunction
biomarker of tubulo-interstitial injury
url http://zmj.zsmu.edu.ua/article/view/223741/228110
work_keys_str_mv AT valysenko therelationshipbetweensystolicfunctionandserumngallevelsinpatientswithchronicheartfailureofischemicorigin
AT vvsyvolap therelationshipbetweensystolicfunctionandserumngallevelsinpatientswithchronicheartfailureofischemicorigin
AT mspotapenko therelationshipbetweensystolicfunctionandserumngallevelsinpatientswithchronicheartfailureofischemicorigin
AT valysenko relationshipbetweensystolicfunctionandserumngallevelsinpatientswithchronicheartfailureofischemicorigin
AT vvsyvolap relationshipbetweensystolicfunctionandserumngallevelsinpatientswithchronicheartfailureofischemicorigin
AT mspotapenko relationshipbetweensystolicfunctionandserumngallevelsinpatientswithchronicheartfailureofischemicorigin